EPA & DHA Market 2024-2032:

  • The global EPA and DHA market size reached USD 1,877.4 Million in 2023.
  • The market is expected to reach USD 3,228.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.
  • Asia Pacific leads the market, accounting for the largest EPA and DHA market share.
  • Docosahexaenoic acid (DHA) accounts for the majority of the market share in the type segment due to its proven benefits for heart health. 
  • Fish oil holds the largest share in the EPA and DHA industry, owing to its high omega-3 content and extensive availability.
  • Dietary supplements remain a dominant segment in the market, due to the convenience and accessibility of these supplements.
  • The increasing consumer focus on health and wellness is a primary driver of the EPA and DHA market.
  • The rising product application in infant nutrition and pharmaceutical industries are reshaping the EPA and DHA market.

Request for a sample copy of this report: https://www.imarcgroup.com/epa-dha-market/requestsample

Industry Trends and Drivers:

  • Rising Health Awareness and Focus on Preventive Care:

The growing emphasis on health and wellness is one of the major drivers boosting the EPA and DHA market share. Moreover, the rising consciousness among consumers about the importance of maintaining a healthy lifestyle, leading to the adoption of ways to prevent chronic diseases, is catalyzing the market growth. Besides this, the growing utilization of EPA and DHA, which are omega-3 fatty acids due to their benefits in reducing heart disease risks, is fueling the market growth. Furthermore, the heightened focus on clinical studies that show their positive effects on blood pressure, cholesterol levels, and inflammation is favoring the market growth.

  • Expanding Applications in Infant Nutrition and Pharmaceuticals:

The growing applications of EPA and DHA in infant nutrition and the pharmaceutical industry are contributing to the market growth. DHA is a crucial nutrient for the development of the brain and eyes in infants, making it a key component in infant formula. In addition to this, the rising demand for infant formula, creating the need for DHA-enriched products is boosting the market growth. Along with this, the EPA and DHA market trends highlight that the rising focus of parents on adopting high-quality nutrition that supports the growth and development of their children is strengthening the market growth.

  • Increasing Demand for Functional Foods and Dietary Supplements:

The rising inclusion of functional foods and dietary supplements in modern diets, encouraging consumers to seek enhanced nutrition in everyday meals, is boosting the EPA and DHA market size. In line with this, the increasing incorporation of EPA and DHA into a wide range of products, including fortified beverages, dairy products, and energy bars, making it easier for consumers to access the health benefits of omega-3s without taking traditional supplements is favoring the market growth. Apart from this, the rising convenience of these fortified products that appeal to busy lifestyles is fostering the market growth. Additionally, the increasing demand for clean-label and natural products, prompting manufacturers to create EPA and DHA-infused items with minimal additives and preservatives, is fueling the market growth.

EPA and DHA Market Report Segmentation:

Breakup By Type:

  • Eicosapentaenoic Acid (EPA) 
  • Docosahexaenoic Acid (DHA) 

Docosahexaenoic acid (DHA) account for the majority of shares as it plays a crucial role in brain and eye development.

Breakup By Source:

  • Fish Oil 
  • Algae Oil
  • Krill Oil
  • Others

Fish oil dominates the market as it is the most abundant and cost-effective source of EPA and DHA, making it widely used in pharmaceutical and nutritional products.

Breakup By Application:

  • Infant Formulae
  • Dietary Supplements
  • Fortified Food and Beverages
  • Pharmaceuticals
  • Others

Dietary supplements exhibit a clear dominance due to growing health awareness.

Breakup By Region:

  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
  • Middle East and Africa ( Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Asia Pacific holds the leading position owing to a large market for EPA and DHA driven by its large population and increasing consumer awareness about the benefits of omega-3s.

Top EPA and DHA Market Leaders:

The EPA and DHA market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

  • AlgiSy BioSciences Inc.
  • Arctic Nutrition AG
  • BASF SE
  • Biosearch Sau
  • Corbion NV
  • Croda International PLC
  • KD Pharma Group
  • Koninklijke DSM NV
  • Nordic Naturals Inc
  • Novasep Holding SAS
  • Novotech Nutraceuticals Inc
  • Omega Protein Corporation
  • Polaris

Ask Analyst Browse full report with TOC List of Figures: https://www.imarcgroup.com/request?type=report&id=7339&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145